Related references
Note: Only part of the references are listed.Possible Existence of α-Sheets in the Amyloid Fibrils Formed by a TTR105-115 Mutant
Mary Rose Hilaire et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
A self-destructive nanosweeper that captures and clears amyloid β-peptides
Qiang Luo et al.
NATURE COMMUNICATIONS (2018)
Chemical and Physical Variability in Structural Isomers of an L/D α-Sheet Peptide Designed To Inhibit Amyloidogenesis
Nathan L. Maris et al.
BIOCHEMISTRY (2018)
Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate
Ting Yang et al.
JOURNAL OF NEUROSCIENCE (2017)
Designed alpha-sheet peptides suppress amyloid formation in Staphylococcus aureus biofilms
Alissa Bleem et al.
NPJ BIOFILMS AND MICROBIOMES (2017)
Delivery of Native Proteins into C-elegans Using a Transduction Protocol Based on Lipid Vesicles
Michele Perni et al.
SCIENTIFIC REPORTS (2017)
Structural differences between amyloid beta oligomers
Leonid Breydo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Peptides Composed of Alternating L- and D-Amino Acids Inhibit Amyloidogenesis in Three Distinct Amyloid Systems Independent of Sequence
Jackson Kellock et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Identifying Aβ-specific pathogenic mechanisms using a nematode model of Alzheimer's disease
Wail M. Hassan et al.
NEUROBIOLOGY OF AGING (2015)
Alzheimer Peptides Aggregate into Transient Nanoglobules That Nucleate Fibrils
Jinghui Luo et al.
BIOCHEMISTRY (2014)
Designed α-sheet peptides inhibit amyloid formation by targeting toxic oligomers
Gene Hopping et al.
ELIFE (2014)
Brain amyloid-β oligomers in ageing and Alzheimer's disease
Sylvain E. Lesne et al.
BRAIN (2013)
β-Amyloid oligomers in aging and Alzheimer's disease
Kathleen R. Zahs et al.
FRONTIERS IN AGING NEUROSCIENCE (2013)
The Monomer State of Beta-Amyloid: Where the Alzheimer's Disease Protein Meets Physiology
M.L. Giuffrida et al.
REVIEWS IN THE NEUROSCIENCES (2011)
Amyloid oligomers: formation and toxicity of A beta oligomers
Masafumi Sakono et al.
FEBS JOURNAL (2010)
Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils
Mahiuddin Ahmed et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Cognitive-Performance Recovery of Alzheimer's Disease Model Mice by Modulation of Early Soluble Amyloidal Assemblies
Anat Frydman-Marom et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Functional Roles of Amyloid-beta Protein Precursor and Amyloid-beta Peptides: Evidence from Experimental Studies
Mikko Hiltunen et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Amide I infrared spectral features characteristic of some untypical conformations appearing in the structures suggested for amyloids
Hajime Torii
JOURNAL OF PHYSICAL CHEMISTRY B (2008)
Plaque-bearing mice with reduced levels of oligomeric amyloid-β assemblies have intact memory function
S. Lesne et al.
NEUROSCIENCE (2008)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
α-sheet:: The toxic conformer in amyloid diseases?
Valerie Daggett
ACCOUNTS OF CHEMICAL RESEARCH (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
3D structure of Alzheimer's amyloid-β(1-42) fibrils
T Lührs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Neurotoxic protein oligomers - what you see is not always what you get
G Bitan et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2005)
FTIR reveals structural differences between native β-sheet proteins and amyloid fibrils
G Zandomeneghi et al.
PROTEIN SCIENCE (2004)
Progress towards a molecular-level structural understanding of amyloid fibrils
R Tycko
CURRENT OPINION IN STRUCTURAL BIOLOGY (2004)
Anatomy of an amyloidogenic intermediate:: Conversion of β-sheet to α-sheet structure in transthyretin at acidic pH
RS Armen et al.
STRUCTURE (2004)
Pauling and Corey's α-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease
RS Armen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Physiological roles of amyloid-beta and implications for its removal in Alzheimer's disease
GM Bishop et al.
DRUGS & AGING (2004)
Increased TNFα production and Cox-2 activity in organotypic brain slice cultures from APPsw transgenic mice
A Quadros et al.
NEUROSCIENCE LETTERS (2003)
Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model
CD Link et al.
NEUROBIOLOGY OF AGING (2003)
Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1-42) in a transgenic Caenorhabditis elegans model
J Drake et al.
NEUROBIOLOGY OF AGING (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Amyloid β-protein (Aβ) assembly:: Aβ40 and Aβ42 oligomerize through distinct pathways
G Bitan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Supramolecular structure in full-length Alzheimer's β-amyloid fibrils:: Evidence for a parallel β-sheet organization from solid-state nuclear magnetic resonance
JJ Balbach et al.
BIOPHYSICAL JOURNAL (2002)
Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies
MP Lambert et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Alzheimer's disease: Genes, proteins, and therapy
DJ Selkoe
PHYSIOLOGICAL REVIEWS (2001)
Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum?
WL Klein et al.
TRENDS IN NEUROSCIENCES (2001)
Structural studies of soluble oligomers of the Alzheimer β-amyloid peptide
THJ Huang et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Elevated Aβ and apolipoprotein E in AβPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease
YM Kuo et al.
MOLECULAR MEDICINE (2000)
Share Paper
